Skip to main content

Renale Osteopathie: Pathogenese und Möglichkeiten der Therapie

  • Conference paper
Die adäquate Dialyse

Zusammenfassung

Störungen des Kalzium- und Phosphatstoffwechsels gehören nicht zu den typischen Komplikationen einer inadäquaten Hämodialyse, obwohl diese Behandlung durchaus in der Lage ist, vorhandene Knochenstoffwechselstörungen zu verschlechtern. Die Entwicklung der renalen Osteopathie beginnt in der Regel lange vor dem Hämodialysestadium, so daß davon ausgegangen werden muß, daß diejenigen Faktoren, die für die Pathogenese der renalen Osteopathie determinierend waren, auch während des Dialysestadiums die führende Rolle spielen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aarskog D, Aksnes L, Lehmann V (1980) Low 1,25-dihydroxy-vitamin D3 in heparin-induced osteopenia. Lancet 2: 650–651

    Article  PubMed  CAS  Google Scholar 

  2. Beehler CJ, Beckner JR, Rosenquist RC, Shankel SW (1980) Parathyroid hormone suppression by cimetidine in the uremic patient. Ann int Med 93: 840–841

    PubMed  CAS  Google Scholar 

  3. Binswanger U, Schiffl H, Huggler M, Becker C (1980) 1,25-Dihydroxycholecalciferol treatment of uremic rats after high magnesium feeding. EDTA Abstracts 17: 10

    Google Scholar 

  4. Bouillon R, Verbeckmoes R, DeMoor P (1975) Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. Kidney Int 7: 422–432

    Article  PubMed  CAS  Google Scholar 

  5. Canterbury JM, Gauellas G, Bourgoignie JJ, Reiss E (1980) Metabolic consequences of oral administration of 24,25-dihydroxycholecalciverol to uremic dogs. J Clin Invest 65: 571–576

    Article  PubMed  CAS  Google Scholar 

  6. Caro JF, Castro JH, Glennon JA (1979) Effect of longerm propranolol administration parathyroid hormone and calcium concentration in primary hyperparathyroidism. Ann Int Med 91: 740–743

    PubMed  CAS  Google Scholar 

  7. Coburn JW, Massry SG (1980) Uses and actions of 1,25-dihydroxyvitamin D3 in uremia. Contrib Nephrol 18

    Google Scholar 

  8. Drüeke T, Bordier PJ, Man NK, Jungers P, Marie -P (1977) Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry and parathyroid hormone in patients with renal osteodystrophy. Kidney Int 11: 267–274

    Article  PubMed  Google Scholar 

  9. Finco D, Olgaard K, Rothstein M, Schwartz J, Korkon A, Teitelbaum S, Klahr S, Slatopolsky E (1981) 24,25(OH)2D3 enhances bone formation in uremia in the abscence of an effect on PTH secretion. Kidney Int 19: 110

    Google Scholar 

  10. Fischer J (1981) Regulation der Biosynthese, der Sekretion and des Stoffwechsels von Parathormon. 5. Nephrologisches Seminar, Heidelberg 1981

    Google Scholar 

  11. Frame B, Sudhaker DR (1980) Calcium-regulating hormones Ann Int Med 93: 928–929

    Google Scholar 

  12. Hesch R-D, Henning HV, Gerlach W, Scheler F (1971) Früherkennung von Störungen der intestinalen Calciumabsorption bei Niereninsuffizienz. Klin Wochenschr 49: 115–120

    Article  PubMed  CAS  Google Scholar 

  13. Horst RL, Littledike ET, Gray RW, Napoli JL (1981) Impaired 24,25dihydroxyvitamin D production in anephric human and pig. J Clin Invest 67: 274–280

    Article  PubMed  CAS  Google Scholar 

  14. Jacob AI, Lambert PW, Canterbury JM, Gauellas G, Bourgoignie JJ (1980) Further studies with cimetidine in uremic dogs. (Abstr.) Am Soc Nephrol 13

    Google Scholar 

  15. Jacob AI, Lanier D, Canterbury J, Bourgoignie JJ (1980) Reduction by cimetidine of serum parathyroid hormone levels in uremic patients. N Eng J Med 302: 671–674

    Article  CAS  Google Scholar 

  16. Kano K, Nonoda A, Yoneshima H, Suda T (1980) Serum concentrations of 25-hydroxyvitamin D in patients with various types of renal disease. Clin Nephrol 14: 274–279

    PubMed  CAS  Google Scholar 

  17. Lilienfeld-Toal HV, Klehr HU (1980) Secondary hyperparathyroidism in early renal failure. Kidney Int 17: 411

    Google Scholar 

  18. Malluche HH, Ritz E, Lange HP, Kutschera J, Hodgson M, Seiffert U, Schoeppe W (1976) Bone histology in incipient and advanced renal failure. Kidney Int 9: 355–362

    Article  PubMed  CAS  Google Scholar 

  19. Malluche HH, Ritz E, Lange HP, Schoeppe W (1976) Changes of bone histology during maintenance hemodialysis at various levels of dialysate calcium concentration. Clin Nephrol 6: 440–448

    PubMed  CAS  Google Scholar 

  20. Malluche HH, Werner E, Ritz E (1978) Intestinal absorption of calcium in incipient and advanced renal failure. Miner Electrolyte Metab 1: 263–270

    CAS  Google Scholar 

  21. Massry SG (1979) Pathogenesis of secondary hyperparathyroidism in early renal failure: a multifactorial system including phosphate retention, skeletal resistance to PTH, and altered vitamin D metabolism. In: Norman AW, Schaefer K et al. (eds) Vitamin D: Basic research and its clinical application. W. de Gruyter, Berlin New York, pp 1203–1207

    Google Scholar 

  22. Massry SG, Goldstein DA, Malluche HH (1980) Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy. Kidney Int 18: 409–418

    Article  PubMed  CAS  Google Scholar 

  23. Pieper R, v Herrath D, Hirsch F-W, Müller B, 0ffermann G, Rottka H, Schaefer K (In Vorbereitung) Failure to show a beneficial effect of oral calcium supplements in human periodontal disease.

    Google Scholar 

  24. Ritz E, Gebest J, Bummer J (1980) Beta-Rezeptorenblocker–eine Therapiemöglichkeit bei renalem sekundärem Hyperparathyreoidismus? Nieren Hochdruckkr 9: 176–180

    Google Scholar 

  25. Ritz E, Mehls O, Krempien B (1980) Calcium and phosphorus metabolism in maintenance hemodialysis. Adv Nephrol 9: 71–108

    CAS  Google Scholar 

  26. Schaefer K (1980) Die Behandlung der urämischen Osteopathie. Dtsch med Wochenschr 105: 1670–1671

    Article  PubMed  CAS  Google Scholar 

  27. Schaefer K, v Herrath D (1981) Aktueller Stand des Vitamin D-Stoffwechsels. Nieren Hochdruckkr 4: 142–147

    Google Scholar 

  28. Schaefer K, v Herrath D (1981) Vitamin D 1980–Eine Bestandsaufnahme. Klin Wochenschr 59: 525–534

    Article  PubMed  CAS  Google Scholar 

  29. Schaefer K, Schaefer P, Koeppe P, Opitz A, Höffler D (1968) Untersuchungen zur Frage der urämischen Osteopathie: Störungen der intestinalen Calcium-Resorption in Abhängigkeit von der Nierenfunktion. Dtsch Med Wochenschr 93: 1018–1022

    Google Scholar 

  30. Scribner BH (im Druck) Is bicarbonate dialysis really any better than acetate dialysis. Controv Nephrol

    Google Scholar 

  31. Slatopolsky E, Gray R, Adams ND et al. (1979) The pathogenesis of secondary hyperparathyroidism in early renal failure. In: Norman AW, Schaefer K et al. (eds) Vitamin D: Basic research and its clinical application. W. de Gruyter, Berlin New York, pp 1209–1215

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schaefer, K., von Herrath, D., Offermann, G. (1982). Renale Osteopathie: Pathogenese und Möglichkeiten der Therapie. In: Streicher, E., Schoeppe, W. (eds) Die adäquate Dialyse. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81765-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81765-6_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11243-3

  • Online ISBN: 978-3-642-81765-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics